dgfulltext.docguide.com
Open in
urlscan Pro
2606:4700::6812:1b7c
Public Scan
Submitted URL: https://dgfulltext.docguide.com/article/novel-image-guided-flexible-probe-transbronchial-microwave-ablation-for-stage-1-lung-can...
Effective URL: https://dgfulltext.docguide.com/article/novel-image-guided-flexible-probe-transbronchial-microwave-ablation-for-stage-1-lung-can...
Submission: On February 08 via manual from US — Scanned from DE
Effective URL: https://dgfulltext.docguide.com/article/novel-image-guided-flexible-probe-transbronchial-microwave-ablation-for-stage-1-lung-can...
Submission: On February 08 via manual from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
You need to enable JavaScript to run this app. ANAESTHESIOLOGY Anaesthesiology * Feedback / Contact Us -------------------------------------------------------------------------------- * Edit Profile -------------------------------------------------------------------------------- * Terms of Use -------------------------------------------------------------------------------- * Privacy Policy -------------------------------------------------------------------------------- * Log Out -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- View Full Text Article Jan 18, 2023 NOVEL IMAGE-GUIDED FLEXIBLE-PROBE TRANSBRONCHIAL MICROWAVE ABLATION FOR STAGE 1 LUNG CANCER. Michael A Pritchett, Janani S Reisenauer, Ryan Kern, David S Wilson BACKGROUND Image-guided percutaneous thermal ablation is an established treatment option for early-stage lung cancer in medically inoperable patients but carries a high risk of pleura-related complications, particularly pneumothorax. click or scroll down to continue reading the article MARINA CHIARA GARASSINO, MD 1.0 CME/MOC TARGETING HER2, HER3, TROP2, AND OTHER ALTERATIONS WITH ADCS IN NSCLC Expert overview of the latest data and recommendations on integrating new treatments into your practice...read more article continues here OBJECTIVE This study aimed to determine if image-guided transbronchial microwave ablation (tMWA) is a feasible approach to treat peripheral stage 1 lung cancer. METHOD A prospective, single-arm, multicenter study sought to enroll 40 adults who were medically inoperable or declined surgery for peripheral stage 1 lung tumors (≤20 mm). Ablation was performed using navigational bronchoscopy and a flexible MWA probe, guided by cone-beam CT with augmented fluoroscopy. Follow-up at 1, 6, and 12 months included CT imaging of the ablation zone and possible tumor recurrence, adverse events (AEs), pulmonary function, and quality of life. RESULTS Across 2 sites, 11 tumors (10 NSCLC, 1 carcinoid) were treated in 10 enrolled patients. Median tumor diameter was 13 × 14 mm (7-19 mm) and median minimum ablative margin was 11 mm (5-19 mm). Technical success and technique efficacy were achieved in all patients. No tumor recurrence was seen during 12-month follow-up. No pneumothorax, pleural effusion, or bronchopleural fistula were noted. Minor AEs included scant hemoptysis, pain, cough, and dyspnea. Two serious AEs occurred ≤30 days of ablation and included a COPD exacerbation (day 9) and a death of unknown cause (day 15). The death led the sponsor to halt enrollment. Pulmonary function and quality-of-life indices remained stable. CONCLUSIONS Image-guided tMWA is a technically feasible approach for peripheral early-stage lung cancer but warrants further evaluation of safety and efficacy in larger cohorts. Source: Respiration; International Review Of Thoracic Diseases Like 1 Comment Email LinkedIn Twitter -------------------------------------------------------------------------------- DAVID G. WARNOCK, MD 0.5 CME PRACTICAL GUIDANCE ON DIAGNOSING AND MANAGING FABRY DISEASE Explore current and emerging options for treatment...read more -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- THE ONCOLOGIST Full Text BRAIN METASTASES FROM BILIARY TRACT CANCER: CASE SERIES AND CLINICOGENOMIC ANALYSIS. BACKGROUND Limited data from small series have suggested that brain metastases from biliary tract cancers (BrM-BTC) affect ≤2% of patients with BTC. We sought to review our experience with patients...read more -------------------------------------------------------------------------------- Like Comment Share -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- NEFROLOGIA Full Text TOCILIZUMAB IN THE TREATMENT OF ACTIVE CHRONIC HUMORAL REJECTION RESISTANT TO STANDARD THERAPY. INTRODUCTION There is no consensus on the most appropriate treatment for chronic active antibody-mediated rejection (cAMR). Recent studies suggest that treatment with tocilizumab (TCZ) may stabilize graft function, decrease the...read more -------------------------------------------------------------------------------- Like Comment Share -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- NEFROLOGIA Full Text ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE IN HLA-IDENTICAL NON-TWIN SIBLINGS. Anti glomerular basement membrane disease (AGBM) is an autoinmune disorder characterised by the presence of anti-glomerular basement membrane (Anti-GBM) antibodies, alveolar hemorrhage, necrotizing glomerulonephritis, and linear deposition of immunoglobulins through...read more -------------------------------------------------------------------------------- Like Comment Share -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI Full Text IMMUNOGENICITY AND SAFETY OF THIRD-DOSE MRNA COVID-19 VACCINES IN HEALTHY ADULTS PREVIOUSLY VACCINATED WITH TWO DOSES OF THE CHADOX1 VACCINE. BACKGROUND/PURPOSE The efficacy and safety of coronavirus disease 2019 (COVID-19) booster vaccines remain limited. We investigated the immunogenicity and adverse events of the third dose of mRNA vaccines in healthy...read more -------------------------------------------------------------------------------- Like Comment Share -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- STEVEN B. DEITELZWEIG, MD, MMM, SFHM, FACP, FACC 1.25 CME/MOC/NCPD/CPE/IPCE TREATING PATIENTS WITH VENOUS THROMBOEMBOLISM Examine the role of DOACs in VTE management across patient populations...read more -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- RHEUMATOLOGY (OXFORD, ENGLAND) Full Text COVID-19 VACCINE AFFECTS NEITHER PROTHROMBOTIC ANTIBODY PROFILE NOR THROMBOSIS IN PRIMARY ANTI-PHOSPHOLIPID SYNDROME: A PROSPECTIVE STUDY. OBJECTIVE To explore whether inactivated coronavirus disease 2019 vaccine influences the profile of prothrombotic autoantibodies and induces thrombotic events in primary APS patients. METHODS We enrolled 39 primary APS patients...read more -------------------------------------------------------------------------------- Like Comment Share -------------------------------------------------------------------------------- © 2023 All rights reserved |Edit Profile|Terms of Use|Privacy Policy (updated January 1, 2022) We use cookies to improve your experience. By using this website, you accept cookies or have set your browser or device to not accept cookies.